Fool - Investing News
13 Jun 2026, 16:20 UTC · 14w ago
Verdict
Headline takes no side. We score PAHC +0.20 across four claims — slightly bullish.
+0.20slightly bullish
More positive than 52% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Phibro Animal Health Corporation expects fiscal 2026 net sales to range between $1.46 billion and $1.5 billion.
So whatForward guidance provides a concrete baseline for valuation and revenue growth expectations.
More positive than 77% of claims this week
Director E. Thomas Corcoran acquired 10,000 shares of PAHC at a weighted average price of $31.77.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 63% of claims this week
Brazil has prohibited the use of feed additives containing certain antibiotics unless a veterinary prescription is provided.
More negative than 79% of claims this week
Phibro Animal Health reported a 10% year-over-year increase in net sales to $383.5 million for the fiscal third quarter ended March 31, 2026.
More positive than 50% of claims this week
Which stocks this story touches
More positive than 52% of ticker scores this week
Positive insider buying and revenue growth are offset by a significant stock price drop and regulatory headwinds in Brazil.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Accesswire
19h ago
+8.2%
Price agrees with the score
$34.10 vs $31.53 close before publication (Jun 12) · not market-adjusted
PAHC chart →
